Light-deprivation Utilized to Mitigate Amblyopia
LUMA
Optimized Visual Recovery in Adult Human Amblyopia Through Binocular Deprivation
2 other identifiers
interventional
8
1 country
1
Brief Summary
Amblyopia is an impairment in spatial vision caused by asymmetry in the quality of visual input across the two eyes during childhood. It is difficult to treat in adulthood because the visual system becomes less "plastic" (able to learn) with age. The purpose of this study is to determine whether five to ten days of visual deprivation--living in complete darkness--can enhance plasticity in the visual cortex and thereby facilitate the learning that is needed to recover visual function in amblyopic adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2016
CompletedFirst Posted
Study publicly available on registry
February 18, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedAugust 29, 2019
August 1, 2019
2.8 years
February 9, 2016
August 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from baseline in Backus Lab Stereoacuity Assessment
4-alternative forced choice task in a stereoscope in the Backus lab. Data will by analyzed for each participant separately and aggregated by mean of change over time.
Twice during the two weeks before sequestration to establish baseline, and again after sequestration: twice weekly for 2 weeks, then weekly for 2 weeks, then 2 times during the next month, monthly for 4 months, and then once every two months for 6 months
Change from baseline in contrast sensitivity function of amblyopic eye, fellow eye, and both eyes together, using the Sentio (R) CSF measurement device
15-20 minute procedure to assess CSF in the amblyopic eye, fellow eye, and using both eyes together. Data will by analyzed for each participant separately and aggregated by mean of change over time.
Twice during the two weeks before sequestration to establish baseline, and again after sequestration: twice weekly for 2 weeks, then weekly for 2 weeks, then 2 times during the next month, monthly for 4 months, and then once every two months for 6 months
Change from baseline in acuity as measured using M&S Technologies automated ETDRS acuity test
5-10 minute procedure to assess logMAR acuity. Data will by analyzed for each participant separately and aggregated by mean of change over time.
Three times during the 2 months before sequestration to establish baseline, and again after sequestration: once a week for 2 weeks, then once a month for 2 months, then once every 3 months until study completion (at approximately 1 year)
Secondary Outcomes (1)
Binocular motor fusion assessment
3 times during the 2 months before sequestration, 4 times during 12 months after sequestration
Other Outcomes (1)
Daily self-report of visual hallucinations
Daily during 5 or 10 days of darkness sequestration
Study Arms (2)
Visual Deprivation - 10 days
EXPERIMENTAL10 days of visual deprivation followed by vision training
Vision Training Only
ACTIVE COMPARATORVision training without visual deprivation
Interventions
Research participants will be asked to live 10 days in an experimentally-controlled dark environment.
Subjects will play a video game on their VR headset for 24 minutes per day, followed by 20 minutes of binocular experience with a brightness-reducing filter over the non-amblyopic eye.
Eligibility Criteria
You may qualify if:
- Adults age 18 or older
- Moderate (20/30 to 20/80) to severe (20/100 to 20/400) amblyopia with a visual acuity of 20/25 or better in the fellow eye
- Must live in or be commutable to the New York Metropolitan area
You may not qualify if:
- individuals with study-relevant phobias, anxiety disorders or other mental health disorders will be excluded, as will people taking anti-depressant or anti-anxiety drugs
- Must pass all stages of application process:
- Review of full application
- Phone interview
- Telephone interview of two personal references
- On-site eligibility screening evaluation
- On-site complete ophthalmic evaluation
- Criminal background check
- On-site personal interview
- Psychological exam
- Physical exam
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- State University of New York College of Optometrylead
- University of Maryland, College Parkcollaborator
- Nova Southeastern Universitycollaborator
- National Eye Institute (NEI)collaborator
Study Sites (1)
SUNY College of Optometry - Clinical Vision Research Center
New York, New York, 10036, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin T Backus, PhD
Grad Ctr for Vision Research, SUNY College of Optometry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 9, 2016
First Posted
February 18, 2016
Study Start
December 1, 2016
Primary Completion
September 30, 2019
Study Completion
December 31, 2019
Last Updated
August 29, 2019
Record last verified: 2019-08